The pharmacokinetics of disopyramide following myocardial infarction with special reference to oral and intravenous dose regimens.

No abstract is available for this paper.

• Publication year

  1976

• Venue

  Journal of International Medical Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 1026529
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The determination of disopyramide in blood plasma and urine.

  1976cited by this paper
• The pharmacokinetics of Norpace.

  1975cited by this paper
• A safe method for rapidly achieving plasma concentration plateaus

  1974cited by this paper
• Problems associated with analysis of pharmacokinetic models.

  1971cited by this paper
• Disopyramide phosphate: pharmacokinetic and pharmacologic relationships of a new antiarrhythmic agent.

  1971cited by this paper
• Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

  1968cited by this paper

• Pharmacokinetics of disopyramide in patients with chronic renal failure

  2010cites this paper
• Kinetics of disopyramide after intravenous infusion to patients with myocardial infarction and heart failure.

  2009cites this paper
• Disopyramide plasma levels in cardiac patients on maintenance therapy.

  2009cites this paper
• PLASMA BINDING OF DISOPYRAMIDE

  2006cites this paper
• Disopyramide in acute myocardial infarction: Problems with changing pharmacokinetics

  2004cites this paper
• Disopyramide pharmacokinetics in patients with acute myocardial infarction

  2004influential citation
• DisopyramideDeterminationby Gas Chromatography , Liquid Chromatography , and Gas Chromatography-MassSpectrometry

  2004cites this paper
• Practical Optimisation of Antiarrhythmic Drug Therapy Using Pharmacokinetic Principles

  1991cites this paper
• Effects of cardiovascular disease on pharmacokinetics

  1989cites this paper
• Procainamide and disopyramide.

  1987cites this paper
• Clinical Pharmacokinetics of Disopyramide

  1986cites this paper
• Disopyramide pharmacokinetics in non-smoking and smoking volunteers : analytical development and effect of phenobarbital on elimination and protein-binding

  1985cites this paper
• Pharmacologically active conformation of disopyramide: evidence from apparent pKa measurements.

  1985cites this paper
• [Disopyramide: its mechanisms of action and clinical use].

  1985cites this paper
• The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias.

  1984cites this paper
• Therapy with conventional antiarrhythmic drugs for ventricular arrhythmias.

  1984cites this paper
• Effect of Concentration-Dependent Binding to Plasma Proteins on the Pharmacokinetics and Pharmacodynamics of Disopyramide

  1984cites this paper
• Disopyramide

  1984cites this paper
• Oral disopyramide after admission to hospital with suspected acute myocardial infarction. U. K. Rythmodan Multicentre Study Group.

  1984cites this paper
• Prolonged variability in plasma protein binding of disopyramide after acute myocardial infarction.

  1983cites this paper
• Disopyramide Plasma Concentrations Following Single and Multiple Doses of the Immediate- and Controlled-Release Capsules

  1983cites this paper
• Therapeutic Drug Monitoring of Antiarrhythmic Agents

  1982cites this paper
• Absorption and antidysrhythmic activity of oral disopyramide phosphate after acute myocardial infarction.

  1982cites this paper
• Clinical pharmacokinetics of disopyramide

  1982cites this paper
• Disopyramide determination by gas chromatography, liquid chromatography, and gas chromatography--mass spectrometry.

  1982cites this paper
• The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide

  1982cites this paper
• The pharmacokinetics of disopyramide in patients with acute myocardial infarction.

  1982cites this paper
• ORAL DISOPYRAMIDE DOSAGE REGIMES IN ISCHAEMIC HEART DISEASE

  1982cites this paper
• Disopyramide pharmacokinetics during recovery from myocardial infarction.

  1982cites this paper
• Plasma disopyramide concentrations following a 300-mg oral loading dose in acute myocardial infarction.

  1982cites this paper
• [The effect of disopyramide, mexiletine and propafenon after intravenous and oral administration on left ventricular function in the M-mode echocardiogram].

  1982cites this paper
• The effects of intravenous disopyramide on cerebral blood flow in volunteers.

  1981cites this paper
• Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure

  1981cites this paper
• Relative absorption of disopyramide as determined by liquid chromatography following acute administration of standard capsules and controlled-release tablets.

  1981cites this paper
• Plasma binding of disopyramide.

  1980cites this paper
• Pharmacokinetics of oral disopyramide phosphate in patients with renal impairment.

  1980cites this paper
• [Pharmacokinetics of anti-arrhythmics. 2. Clinical applications].

  1980cites this paper
• Intravenous and oral disopyramide after myocardial infarction.

  1980cites this paper
• The effect of metoclopramide and atropine on the absorption of orally administered mexiletine.

  1980cites this paper
• Disposition kinetics of disopyramide in patients with renal insufficiency

  1980cites this paper
• Aromatic amino acetylation in the adult and neonatal marmoset [proceedings].

  1979cites this paper
• Collapse after oral disopyramide.

  1979cites this paper
• Disopyramide kinetics in patients with acute myocardial infarction

  1979cites this paper
• Electrophysiological and Hemodynamic Disturbances in a Patient Overdosed with Disopyramide

  1979cites this paper
• [Anti-arrhythmia agents].

  1979cites this paper
• Recurrent ventricular tachycardia in man: evaluation of disopyramide therapy by intracardiac electrical stimulation.

  1979cites this paper
• [Antiarrhythmic action of disopyramide: a study of plasma levels].

  1979cites this paper
• Role of concentration-dependent plasma protein binding in disopyramide disposition

  1979cites this paper
• Pharmacokinetics of disopyramide administered by intramuscular, intravenous and oral routes to normal volunteers [proceedings].

  1979cites this paper
• Suppression of ventricular arrhythmias with intravenous disopyramide and lidocaine: efficacy comparison in a randomized trial.

  1979cites this paper
• The renal clearance of disopyramide after bolus intravenous injection

  1979cites this paper
• Gas-liquid chromatographic method for the routine estimation of disopyramide in plasma or serum.

  1978cites this paper
• Disopyramide in myocardial infarction.

  1978cites this paper
• The absorption of oral mexiletine in coronary care patients

  1978cites this paper
• Assay of disopyramide in plasma by high-pressure liquid chromatography.

  1978cites this paper
• Pharmacokinetics of antiarrhythmic drugs.

  1978cites this paper
• Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias.

  1978cites this paper
• [Pharmacokinetic study of disopyramide in normal man].

  1978cites this paper
• Disopyramide (Norpace® — Searle)

  1978cites this paper
• Simple gas-liquid chromatographic method for the measurement of disopyramide in blood-plasma or serum and in urine.

  1978cites this paper
• The Effects of Urine pH and Plasma Protein Binding on the Renal Clearance of Disopyramide

  1977cites this paper
• Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods.

  1977cites this paper
• Oral dosage schedules for mexiletine.

  1977cites this paper
• Arrhythmia prevention in early myocardial infarction.

  1977cites this paper
• Disopyramide—A Review

  1977cites this paper
• Letter: Disopyramide dose.

  1976cites this paper